Reduced Use of Antibiotics and Nasal Decongestants During Treatment with a Mouthwash Containing Delmopinol
2023

Reduced Use of Antibiotics and Nasal Decongestants with Delmopinol Mouthwash

Sample size: 686 publication Evidence: high

Author Information

Author(s): Sjödin Torgny, Movert Rolf, Åström Mikael

Primary Institution: Biosurface AB; Faculty of Odontology, Malmö University

Hypothesis

Does the use of a mouthwash containing delmopinol HCl 0.2% reduce the need for concomitant medications like antibiotics and nasal decongestants in patients with gingivitis?

Conclusion

The delmopinol HCl 0.2% solution significantly reduced the use of antibiotics and nasal decongestants in patients with gingivitis.

Supporting Evidence

  • Patients using delmopinol 0.2% had a 27% lower number of antibiotic treatments compared to placebo.
  • A 41% reduction in antibiotic treatments for respiratory infections was observed in the delmopinol group.
  • The delmopinol group had a 53% lower number of nasal decongestant treatments compared to placebo.

Takeaway

Using a special mouthwash can help people with gum disease use fewer medicines for infections and stuffy noses.

Methodology

Data from 8 phase III randomized double-blind studies were analyzed to compare the use of concomitant medications between patients using delmopinol mouthwash and those using placebo.

Potential Biases

Potential bias may arise from the study design and the involvement of the manufacturers in the research.

Limitations

The studies were conducted primarily on patients with gingivitis, which may limit the generalizability of the findings to other populations.

Participant Demographics

Patients aged 18 to 73 years, with about 60% men and 40% women, and a mix of smokers and non-smokers.

Statistical Information

P-Value

0.03

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3290/j.ohpd.b4586769

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication